Artificial intelligence can assist providers in a variety of patient care and intelligent health
systems. Artificial intelligence techniques ranging from machine learning to deep learning …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

This paper explores the potential impact of Generative Artificial Intelligence (Generative AI)
on developing countries, considering both positive and negative effects across various …

Background The increasing development of artificial intelligence (AI) systems in medicine
driven by researchers and entrepreneurs goes along with enormous expectations for …

Pulmonary arterial hypertension (PAH) is a devastating complication of systemic sclerosis
(SSc). Screening for PAH in SSc has increased detection, allowed early treatment for PAH …

As the world produces exabytes of data, there is a growing need to find new methods that
are more suitable for dealing with complex datasets. Artificial intelligence (AI) has significant …

Pulmonary hypertension is a complex disease with multiple causes, corresponding to
phenotypic heterogeneity and variable therapeutic responses. Advancing understanding of …

Abstract Background and aims Artificial Intelligence (AI) shows extensive capabilities to
impact different healthcare areas during the COVID-19 pandemic positively. This paper tries …

Background Pulmonary arterial hypertension (PAH) is a rare but life shortening disease, the
diagnosis of which is often delayed, and requires an invasive right heart catheterisation …

The role of Artificial Intelligence (AI) in clinical decision-making raises issues of trust. One
issue concerns the conditions of trusting the AI which tends to be based on validation …